Ocular Manifestations in Patients with Type 2 Diabetes Mellitus: Relationship with duration and severity of the Disease
Authors/Creators
- 1. Associate Professor, Department of Ophthalmology, PGIMER and CH, Bhubaneswar, Odisha, India
- 2. Associate Professor, Department of Biochemistry, PGIMER and CH, Bhubaneswar, Odisha, India
- 3. Senior Resident, Department of Ophthalmology, PGIMER and CH, Bhubaneswar, Odisha, India
Description
Background: Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by hyperglycemia. Ocular manifestations are among the most common and debilitating complications of T2DM. Objective: The objective of this study is to find out different ocular manifestations in patients with Type 2 Diabetes Mellitus of a duration of 0 – 5 years and its relation with the duration and severity of the disease. Methods: A prospective observational study of ocular manifestations in patients with Type 2 Diabetes Mellitus (T2DM) of duration 0-5 years attending tertiary care center, Bhubaneswar for 12 months. Detailed history, complete ocular examination, and relevant investigations were done on 560 eyes of 280 patients. Results: Out of 280 patients evaluated 130 (46.42%) were male and 150 (53.57%) were female. The most common ocular manifestation was cataract 121 (21.6%), followed by Diabetic retinopathy 48(8.57%), POAG 6(1.07%), Diabetic papillopathy 4(0.7%), BRVO 2(0.3%), 3rd Nerve palsy(0.3%). The most common type of cataract found was posterior subcapsular cataract 12(44.4%) among patients of T2DM of duration less than one year, nuclear type 64% among patients of T2DM of duration 1 to 5 years. Conclusion: These ocular findings suggest that an annual eye examination should initiated at the time of diabetes diagnosis, as it will help reduce visual morbidity.
Abstract (English)
Background: Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by hyperglycemia. Ocular manifestations are among the most common and debilitating complications of T2DM. Objective: The objective of this study is to find out different ocular manifestations in patients with Type 2 Diabetes Mellitus of a duration of 0 – 5 years and its relation with the duration and severity of the disease. Methods: A prospective observational study of ocular manifestations in patients with Type 2 Diabetes Mellitus (T2DM) of duration 0-5 years attending tertiary care center, Bhubaneswar for 12 months. Detailed history, complete ocular examination, and relevant investigations were done on 560 eyes of 280 patients. Results: Out of 280 patients evaluated 130 (46.42%) were male and 150 (53.57%) were female. The most common ocular manifestation was cataract 121 (21.6%), followed by Diabetic retinopathy 48(8.57%), POAG 6(1.07%), Diabetic papillopathy 4(0.7%), BRVO 2(0.3%), 3rd Nerve palsy(0.3%). The most common type of cataract found was posterior subcapsular cataract 12(44.4%) among patients of T2DM of duration less than one year, nuclear type 64% among patients of T2DM of duration 1 to 5 years. Conclusion: These ocular findings suggest that an annual eye examination should initiated at the time of diabetes diagnosis, as it will help reduce visual morbidity.
Files
IJTPR,Vol14,Issue12,Article45.pdf
Files
(461.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ced17bfc1a83d41aef534a99d1d81a5d
|
461.3 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-11-28
Software
References
- 1. WHO Diabetes june 2021 2. Anjana RM, Unnikrishnan R, Deepa M, Pradeepa R, Tandon N, Das AK, Joshi S, Bajaj S, Jabbar PK, Das HK, Kumar A, Dhandhania VK, Bhansali A, Rao PV, Desai A, Kalra S, Gupta A, Lakshmy R, Madhu SV, Elangovan N, Chowdhury S, Venkatesan U, Subashini R, Kaur T, Dhaliwal RS, Mohan V; ICMRINDIAB Collaborative Study Group. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national crosssectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023 Jul;11(7):474-489. doi: 10.1016/S2213-8587(23)00119-5. Epub 2023 Jun 7. PMID: 37301218. 3. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition, Saeedi, Pouya et al. Diabetes Research and Clinical Practice, Volume 157, 10784 4. Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res. 2007; 2007:43603. doi: 10.1155/2007/43603. PMID: 17641741; PMCID: PMC1880867. 5. Lotfy M, Adeghate J, Kalasz H, Singh J, Adeghate E. Chronic Complications of Diabetes Mellitus: A Mini Review. Curr Diabetes Rev. 2017;13(1):3-10. doi: 10.2174/1573399812666151016101622. PMID: 26472574. 6. Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care. 2004 Oct;27(10):2540-53. doi: 10.2337/diacare.27.10.2540. PMID: 15451934. 7. UK Prospective Diabetes Study (UKPDS) Group Risk of complication in type 2 DM Lancet 352;837-853,1998 8. Skyler JS. Diabetic complications. The importance of glucose control. Endocrinol Metab Clin North Am. 1996 Jun;25(2):243- 54. doi: 10.1016/s0889-8529(05)70323-6. PMID: 8799699. 9. Kaur G, Baldev VF, Sharma M et. al. Diabetic retinopathy: are the general practitioners adequately aware? Int J Health Sci Res. 2015; 5(5):115-123 10. Raman, Rajiv; Ramasamy, Kim1; Rajalakshmi, Ramachandran2; Sivaprasad, Sobha3; Natarajan, S4. Diabetic retinopathy screening guidelines in India: All India Ophthalmological Society diabetic retinopathy task force and Vitreoretinal Society of India Consensus Statement. Indian Journal of Ophthalmology 69(3):p 678-688, March 2021. | DOI: 10.4103/ijo.IJO_667_20 11. Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991 May;98(5 Suppl):786- 806. PMID: 2062513. 12. Kautzky-Willer, Jürgen Harreiter, Giovanni Pacini, Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus, Endocrine Reviews, Volume 37, Issue 3, 1 June 2016, Pages 278–316, https://doi.org/10.1210/er.2015 13. Deepa R , Anuradha P . Evaluation of ocular manifestations in Type 2 Diabetes mellitus. Indian J Clin Exp Ophthalmol 2020;6(3):338- 342. 14. Seid, M.A., Ambelu, A., Diress, M. et al. Visual impairment and its predictors among people living with type 2 diabetes mellitus at Dessie town hospitals, Northeast Ethiopia: institution-based cross-sectional study. BMC Ophthalmol 22, 52 (2022) https://doi.org/10.1186/s12886-022-02292-3 15. Prevalence of visual impairment and associated risk factors in subjects with type II diabetes mellitus: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study [SN-DREAMS, report 16] Padmaja Kumari, Rani ; Rajiv, Raman ; Laxmi, Gella ; Vaitheeswaran, Kulothungan ; Tarun, Sharma. MEAJO-Middle East African Journal of Ophthalmology. 2012; 19 (1): 129-134 16. De Fine Olivarius, N., Siersma, V., Almind, G.J. et al. Prevalence and progression of visual impairment in patients newly diagnosed with clinical type 2 diabetes: a 6-year follow up study. BMC Public Health 11, 80 (2011). https://doi.org/10.1186/1471-2458-11-80 17. Bayraktar, Zerrin MD; Alacali, Nilay MD; Bayraktar, Sükrü MD†. Diabetic Papillopathy In Type Ii Diabetic Patients. Retina 22(6):p 752-758, December 2002. 18. Umarani, Shilpa; Dollaiah, Ashwini; Vallabha, K. Prospective Clinical Study of Ocular Manifestations in Patients with Type 2 Diabetes Mellitus. TNOA Journal of Ophthalmic Science and Research 60(1):p 23-29, Jan–Mar 2022. | DOI: 10.4103/tjosr.tjosr_153_21 19. Kruse A, Thomsen RW, Hundborg HH, Knudsen LL, Sørensen HT, Schønheyder HC. Diabetes and risk of acute infectious conjunctivitis--a population-based case-control study. Diabet Med. 2006 Apr;23(4):393-7. doi: 10.1111/j.1464-5491.2006.01812. x. PMID: 16620267 20. Raman, R., Gupta, A., Krishna, S., Kulothungan, V., & Sharma, T. (2012). Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27). Journal of Diabetes and its Complications 26(2), 123-128. https://doi.org/10.1016/j.jdiacomp.2012.02.00 1 21. Lathika, V. K., & Ajith, T. A. (2017). Association of grade of cataract with duration of diabetes, age and gender in patients with type II diabetes mellitus. International Journal of Advances in Medicine, 3(2), 304–308. https://doi.org/10.18203/2349- 3933.ijam20161080. 22. Narendran V, John RK, Raghuram A, Ravindran RD, Nirmalan PK, Thulasiraj RD. Diabetic retinopathy among self-reported diabetics in southern India: a population-based assessment. Br J Ophthalmol. 2002 Sep;86(9):1014-8. doi: 10.1136/bjo.86.9.1014. PMID: 12185129; PMCID: PMC1771268. 23. Visual impairment in Diabetes, Ronald Klein MD, Barbara E.K. Klein MD, Scot E. Moss MA, Ophthalmology vol 91 1984